| Cytokines expression in SLE nephritis A Gigante, ML Gasperini, A Afeltra, B Barbano, D Margiotta, R Cianci, ... Eur Rev Med Pharmacol Sci 15 (1), 15-24, 2011 | 89 | 2011 |
| Development of clinical simultaneous SPECT/MRI FC Hutton BF, Occhipinti M, Kuehne A, Máthé D, Kovács N, Waiczies H ... Br J Radiol., 2017 | 79* | 2017 |
| Revascularization versus medical therapy for renal artery stenosis: antihypertensive drugs and renal outcome R Cianci, P Martina, F Borghesi, D Di Donato, L Polidori, S Lai, G Ascoli, ... Angiology 62 (1), 92-99, 2011 | 31 | 2011 |
| Intensity-modulated radiotherapy and anal cancer: clinical outcome and late toxicity assessment I De Francesco, K Thomas, L Wedlake, D Tait Clinical oncology 28 (9), 604-610, 2016 | 14 | 2016 |
| Penile Kaposi’s sarcoma V Grandi, I De Francesco New England Journal of Medicine 382 (12), e20, 2020 | 5 | 2020 |
| Nephroangiosclerosis and its pharmacological approach R Cianci, B Barbano, P Martina, A Gigante, L Polidori, S Lai, G Ascoli, ... Current vascular pharmacology 9 (2), 238-243, 2011 | 5 | 2011 |
| Diffusion-weighted magnetic resonance imaging in painful bone metastases: Using quantitative apparent diffusion coefficient as an indicator of effectiveness of single fraction … D Musio, I De Francesco, A Galdieri, C Marsecano, A Piciocchi, A Napoli, ... European Journal of Radiology 98, 1-6, 2018 | 4 | 2018 |
| Solitary rib metastasis of nasopharyngeal carcinoma F De Felice, D Musio, AL Magnante, N Bulzonetti, I De Francesco, ... Chinese Journal of Cancer Research 26 (2), 219, 2014 | 4 | 2014 |
| INSERT: A novel clinical scanner for simultaneous SPECT/MRI brain studies BF Hutton, K Erlandsson, D Salvado, M Occhipinti, Z Papp, B Tölgyesi, ... 2017 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC …, 2017 | 3 | 2017 |
| Pelvic Intensity-modulated Radiotherapy: Can we Better Quantify the Late Side-effects? TDM De Francesco I, Thomas K Clinical Oncology (Royal College of Radiologist) 27 (7), 428, 2015 | 2* | 2015 |
| Integrated SPECT-MRI for enhanced stratification and early treatment response assessment in glioma S Short, B Hutton, L Ottobrini, I De Francesco, C Fiorini Neuro-Oncology 20 (Suppl 1), i2, 2018 | 1 | 2018 |
| A case of cutaneous peripheral T-cell not otherwise specified (PTCL-NOS), successfully treated with brentuximab vedotin after disease progression on standard chemotherapy I De Francesco, M Wain, D Wong, F Child, D Dasgupta, S Whittaker, ... European Journal of Cancer 156, S57-S58, 2021 | | 2021 |
| PO-1078 HDR brachytherapy for treatment of primary cutaneous lymphoma at complex sites and curved surfaces V Sim, I De Francesco, S Whittaker, F Child, M Wain, S Aldridge, E Jones, ... Radiotherapy and Oncology 161, S896-S897, 2021 | | 2021 |
| Dosimetric comparison of brachytherapy and Tomotherapy for a large SCC on the scalp RG Vaz, E Jones, R Begum, A Dobson, S Morris, I De Francesco Radiotherapy and Oncology 158, S219-S220, 2021 | | 2021 |
| Non-Melanoma Skin Cancer I De Francesco, S Whittaker, SL Morris Treatment of Cancer, 375-409, 2020 | | 2020 |
| Treatment of mycosis fungoides/Sezary syndrome with brentuximab vedotin on the compassionate use program and CDF: outcomes and toxicities S Enefer, V Grandi, I De Francesco, S Morris European Journal of Cancer 119, S29, 2019 | | 2019 |
| Results of radical chemoradiotherapy for oesophageal and junctional cancers: The Royal Marsden Hospital experience L Bernier, I De Francesco, D Tait European Journal of Cancer 1 (72), S82, 2017 | | 2017 |
